-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Agile Therapeutics Inc quarterly/annual Depreciation history and growth rate from Q1 2014 to Q1 2024.
- Agile Therapeutics Inc Depreciation for the quarter ending March 31, 2024 was $26K, unchanged year-over-year.
- Agile Therapeutics Inc annual Depreciation for 2023 was $102K, a 92% decline from 2022.
- Agile Therapeutics Inc annual Depreciation for 2022 was $1.28M, a 38% decline from 2021.
- Agile Therapeutics Inc annual Depreciation for 2021 was $2.06M, a 1866% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)